|

Spironolactone Clinical Trials

7 actively recruiting trials across 3 locations

Also known as: S, Spironolactone Mylan 25mg

Pipeline

Early 1: 2Phase 2: 2Phase 3: 1Phase 1/2: 2

Top Sponsors

  • University of Virginia2
  • University Hospital, Strasbourg, France1
  • Lantern Pharma Inc.1
  • Hospices Civils de Lyon1
  • Fundació Sant Joan de Déu1

Indications

  • Cancer4
  • Heart Disease2
  • Puberty2
  • Hyperandrogenism2
  • Polycystic Ovary Syndrome2

Other3 trials

A Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of a Fixed Dose Combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) in Polycystic Ovary Syndrome (PCOS)
Phase 2
Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD
Phase 2
Evaluation of Spironolactone Efficacy in Patient with Rheumatoid Arthritis (RA)
Phase 3

Charlottesville, Virginia2 trials

Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism?

Center for Research in Reproduction, University of Virginia

Early 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns

University of Virginia Clinical Research Unit

Early 1

Springdale, Arkansas1 trial

Study of LP-184 in Patients With Advanced Solid Tumors

Highlands Oncology Group

Phase 1/2

Philadelphia, Pennsylvania1 trial

Fibrosis and the Fontan

Children's Hospital of Philadelphia

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.